{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,4]],"date-time":"2026-11-04T23:34:55Z","timestamp":1793835295730,"version":"4.6.1"},"reference-count":25,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2011,10,11]],"date-time":"2011-10-11T00:00:00Z","timestamp":1318291200000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Med Oncol"],"published-print":{"date-parts":[[2012,9]]},"DOI":"10.1007\/s12032-011-0075-x","type":"journal-article","created":{"date-parts":[[2011,10,10]],"date-time":"2011-10-10T19:48:50Z","timestamp":1318276130000},"page":"1843-1849","source":"Crossref","is-referenced-by-count":35,"title":["Decreased expression of ALDH1L1 is associated with a poor prognosis in hepatocellular carcinoma"],"prefix":"10.1007","volume":"29","author":[{"given":"Xiao-Qian","family":"Chen","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Juan-Ru","family":"He","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hui-Yun","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2011,10,11]]},"reference":[{"issue":"3","key":"75_CR1","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1016\/S0168-8278(01)00130-1","volume":"35","author":"J Bruix","year":"2001","unstructured":"Bruix J, et al. Clinical management of hepatocellular carcinoma. Conclusions of the Barcelona-2000 EASL conference. European association for the study of the liver. J Hepatol. 2001;35(3):421\u201330.","journal-title":"J Hepatol"},{"issue":"11","key":"75_CR2","doi-asserted-by":"crossref","first-page":"1124","DOI":"10.1056\/NEJMsa050467","volume":"353","author":"J He","year":"2005","unstructured":"He J, et al. Major causes of death among men and women in China. N Engl J Med. 2005;353(11):1124\u201334.","journal-title":"N Engl J Med"},{"issue":"27","key":"75_CR3","doi-asserted-by":"crossref","first-page":"3771","DOI":"10.1038\/sj.onc.1209560","volume":"25","author":"LB Seeff","year":"2006","unstructured":"Seeff LB, Hoofnagle JH. Epidemiology of hepatocellular carcinoma in areas of low hepatitis B and hepatitis C endemicity. Oncogene. 2006;25(27):3771\u20137.","journal-title":"Oncogene"},{"issue":"2","key":"75_CR4","first-page":"126","volume":"1765","author":"F Feo","year":"2006","unstructured":"Feo F, et al. Hepatocellular carcinoma as a complex polygenic disease. Interpretive analysis of recent developments on genetic predisposition. Biochim Biophys Acta. 2006;1765(2):126\u201347.","journal-title":"Biochim Biophys Acta"},{"issue":"3","key":"75_CR5","doi-asserted-by":"crossref","first-page":"308","DOI":"10.3350\/kjhep.2010.16.3.308","volume":"16","author":"OS Kwon","year":"2010","unstructured":"Kwon OS, et al. Effect of alcohol on the development of hepatocellular carcinoma in patients with hepatitis B virus-related cirrhosis: a cross-sectional case-control study. Korean J Hepatol. 2010;16(3):308\u201314.","journal-title":"Korean J Hepatol"},{"issue":"3","key":"75_CR6","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1002\/jso.20051","volume":"86","author":"K Chen Ban","year":"2004","unstructured":"Chen Ban K, et al. Comparison of the expression of beta-catenin in hepatocellular carcinoma in areas with high and low levels of exposure to aflatoxin B1. J Surg Oncol. 2004;86(3):157\u201363.","journal-title":"J Surg Oncol"},{"issue":"3","key":"75_CR7","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1055\/s-2007-1007117","volume":"19","author":"FX Bosch","year":"1999","unstructured":"Bosch FX, Ribes J, Borras J. Epidemiology of primary liver cancer. Semin Liver Dis. 1999;19(3):271\u201385.","journal-title":"Semin Liver Dis"},{"issue":"1\u20133","key":"75_CR8","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1016\/j.cbi.2008.09.007","volume":"178","author":"SA Krupenko","year":"2009","unstructured":"Krupenko SA. FDH: an aldehyde dehydrogenase fusion enzyme in folate metabolism. Chem Biol Interact. 2009;178(1\u20133):84\u201393.","journal-title":"Chem Biol Interact"},{"issue":"5","key":"75_CR9","first-page":"227","volume":"13","author":"SA Krupenko","year":"2002","unstructured":"Krupenko SA, Oleinik NV. 10-formyltetrahydrofolate dehydrogenase one of the major folate enzymes, is down-regulated in tumor tissues and possesses suppressor effects on cancer cells. Cell Growth Differ. 2002;13(5):227\u201336.","journal-title":"Cell Growth Differ"},{"issue":"2","key":"75_CR10","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1042\/bj1580341","volume":"158","author":"HA Krebs","year":"1976","unstructured":"Krebs HA, Hems R, Tyler B. The regulation of folate and methionine metabolism. Biochem J. 1976;158(2):341\u201353.","journal-title":"Biochem J"},{"issue":"49","key":"75_CR11","doi-asserted-by":"crossref","first-page":"15772","DOI":"10.1021\/bi9619684","volume":"35","author":"DW Kim","year":"1996","unstructured":"Kim DW, et al. Properties of tetrahydropteroylpentaglutamate bound to 10-formyltetrahydrofolate dehydrogenase. Biochemistry. 1996;35(49):15772\u201383.","journal-title":"Biochemistry"},{"issue":"1","key":"75_CR12","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1006\/abbi.1995.1021","volume":"316","author":"C Wagner","year":"1995","unstructured":"Wagner C, et al. 10-Formyltetrahydrofolate dehydrogenase: identification of the natural folate ligand, covalent labeling, and partial tryptic digestion. Arch Biochem Biophys. 1995;316(1):141\u20137.","journal-title":"Arch Biochem Biophys"},{"issue":"8","key":"75_CR13","first-page":"577","volume":"1","author":"NV Oleinik","year":"2003","unstructured":"Oleinik NV, Krupenko SA. Ectopic expression of 10-formyltetrahydrofolate dehydrogenase in A549 cells induces G1 cell cycle arrest and apoptosis. Mol Cancer Res. 2003;1(8):577\u201388.","journal-title":"Mol Cancer Res"},{"issue":"47","key":"75_CR14","doi-asserted-by":"crossref","first-page":"6233","DOI":"10.1038\/onc.2010.356","volume":"29","author":"NV Oleinik","year":"2010","unstructured":"Oleinik NV, Krupenko NI, Krupenko SA. ALDH1L1 inhibits cell motility via dephosphorylation of cofilin by PP1 and PP2A. Oncogene. 2010;29(47):6233\u201344.","journal-title":"Oncogene"},{"issue":"2","key":"75_CR15","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1002\/1097-0142(20010715)92:2<395::AID-CNCR1335>3.0.CO;2-U","volume":"92","author":"D Tackels-Horne","year":"2001","unstructured":"Tackels-Horne D, et al. Identification of differentially expressed genes in hepatocellular carcinoma and metastatic liver tumors by oligonucleotide expression profiling. Cancer. 2001;92(2):395\u2013405.","journal-title":"Cancer"},{"issue":"6","key":"75_CR16","doi-asserted-by":"crossref","first-page":"1101","DOI":"10.1038\/nprot.2008.73","volume":"3","author":"TD Schmittgen","year":"2008","unstructured":"Schmittgen TD, Livak KJ. Analyzing real-time PCR data by the comparative C(T) method. Nat Protoc. 2008;3(6):1101\u20138.","journal-title":"Nat Protoc"},{"issue":"4","key":"75_CR17","doi-asserted-by":"crossref","first-page":"779","DOI":"10.1093\/jn\/129.4.779","volume":"129","author":"LB Bailey","year":"1999","unstructured":"Bailey LB, Gregory JF 3rd. Folate metabolism and requirements. J Nutr. 1999;129(4):779\u201382.","journal-title":"J Nutr"},{"key":"75_CR18","doi-asserted-by":"crossref","first-page":"320","DOI":"10.1016\/0968-0004(84)90302-5","volume":"9","author":"SJ Benkovic","year":"1984","unstructured":"Benkovic SJ. The transformylase enzymes in de novo purine biosynthesis. Trends Biochem Sci. 1984;9:320\u20132.","journal-title":"Trends Biochem Sci"},{"issue":"6","key":"75_CR19","doi-asserted-by":"crossref","first-page":"1288","DOI":"10.1124\/mol.60.6.1288","volume":"60","author":"MS Jhaveri","year":"2001","unstructured":"Jhaveri MS, Wagner C, Trepel JB. Impact of extracellular folate levels on global gene expression. Mol Pharmacol. 2001;60(6):1288\u201395.","journal-title":"Mol Pharmacol"},{"issue":"5","key":"75_CR20","doi-asserted-by":"crossref","first-page":"1752","DOI":"10.1523\/JNEUROSCI.22-05-01752.2002","volume":"22","author":"II Kruman","year":"2002","unstructured":"Kruman II, et al. Folic acid deficiency and homocysteine impair DNA repair in hippocampal neurons and sensitize them to amyloid toxicity in experimental models of Alzheimer\u2019s disease. J Neurosci. 2002;22(5):1752\u201362.","journal-title":"J Neurosci"},{"issue":"1","key":"75_CR21","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1093\/jn\/129.1.25","volume":"129","author":"RF Huang","year":"1999","unstructured":"Huang RF, et al. Folate deficiency induces a cell cycle-specific apoptosis in HepG2 cells. J Nutr. 1999;129(1):25\u201331.","journal-title":"J Nutr"},{"issue":"12","key":"75_CR22","doi-asserted-by":"crossref","first-page":"1194","DOI":"10.1097\/NEN.0b013e31818fbe1e","volume":"67","author":"FJ Rodriguez","year":"2008","unstructured":"Rodriguez FJ, et al. Gene expression profiling of NF-1-associated and sporadic pilocytic astrocytoma identifies aldehyde dehydrogenase 1 family member L1 (ALDH1L1) as an underexpressed candidate biomarker in aggressive subtypes. J Neuropathol Exp Neurol. 2008;67(12):1194\u2013204.","journal-title":"J Neuropathol Exp Neurol"},{"issue":"Pt 3","key":"75_CR23","doi-asserted-by":"crossref","first-page":"503","DOI":"10.1042\/BJ20050533","volume":"391","author":"NV Oleinik","year":"2005","unstructured":"Oleinik NV, et al. Cancer cells activate p53 in response to 10-formyltetrahydrofolate dehydrogenase expression. Biochem J. 2005;391(Pt 3):503\u201311.","journal-title":"Biochem J"},{"issue":"51","key":"75_CR24","doi-asserted-by":"crossref","first-page":"7222","DOI":"10.1038\/sj.onc.1210526","volume":"26","author":"NV Oleinik","year":"2007","unstructured":"Oleinik NV, Krupenko NI, Krupenko SA. Cooperation between JNK1 and JNK2 in activation of p53 apoptotic pathway. Oncogene. 2007;26(51):7222\u201330.","journal-title":"Oncogene"},{"issue":"1","key":"75_CR25","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1158\/1541-7786.MCR-08-0309","volume":"7","author":"S Ghose","year":"2009","unstructured":"Ghose S, et al. 10-formyltetrahydrofolate dehydrogenase-induced c-Jun-NH2-kinase pathways diverge at the c-Jun-NH2-kinase substrate level in cells with different p53 status. Mol Cancer Res. 2009;7(1):99\u2013107.","journal-title":"Mol Cancer Res"}],"container-title":["Medical Oncology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s12032-011-0075-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s12032-011-0075-x\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s12032-011-0075-x","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,6,17]],"date-time":"2019-06-17T08:29:57Z","timestamp":1560760197000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s12032-011-0075-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2011,10,11]]},"references-count":25,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2012,9]]}},"alternative-id":["75"],"URL":"https:\/\/doi.org\/10.1007\/s12032-011-0075-x","relation":{},"ISSN":["1357-0560","1559-131X"],"issn-type":[{"value":"1357-0560","type":"print"},{"value":"1559-131X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2011,10,11]]}}}